• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

brodalumab - Articles and news items


Brodalumab treatment improved clinical signs and symptoms in Phase 2 psoriatic arthritis study published in The New England Journal Of Medicine

Industry news / 12 June 2014 / Amgen

Phase 3 program underway to further assess Brodalumab as potential treatment for people living with psoriatic arthritis…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +